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Summary
We wished to investigate the ability of different SNP chipsets to detect association with a disease and to investigate
the linkage disequilibrium (LD) relationships between microsatellites and nearby SNPs in order to assess their potential
usefulness to detect association.
SNP genotypes were obtained from HapMap and microsatellite genotypes from CEPH. 5000 SNPs were simulated as
disease genes which increased penetrance from 0.01 to 0.02 in a sample of 400 cases and 400 controls. The power of
ﬂanking SNPs to detect association was tested using sets of 1, 2, 3 or 4 markers analysed with haplotype analysis or logistic
regression and using either all HapMap markers or those from the Affymetrix 500K, Illumina 300K or Illumina 550K
chipsets. Additionally, LD relationships between 10 microsatellites and SNPs within 2Mb of each other were studied.
The power for one of the markers to detect association at p = 0.001 was around 0.4. Power was slightly better for logistic
regression than haplotype analysis and for two-marker as opposed to single marker analysis but analysing with larger
numbers markers had little beneﬁt. The Illumina 550K marker set was better able to detect association than the other two
and was almost as powerful as using all HapMap markers. Microsatellites had detectable LD with only a small number of
nearby SNPs and the pattern of LD was very variable.
Available chipsets have quite good ability to detect association although obviously results will be critically dependent on
the nature of the genetic effect on risk, sample size and the actual LD relationships of the susceptibility polymorphisms
involved. Microsatellites seem ill-suited for systematic studies to detect association.
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Introduction
Many previous investigations have used simulation stud-
ies to investigate the ability of SNPs to detect associa-
tion. Our own group has carried out two such studies to
characterise the ability of marker polymorphisms to detect
association with nearby variants inﬂuencing susceptibility
to a disease (North et al. 2004; North et al. 2006). A previ-
ous report assessed the relative power of Affymetrix 100K,
Affymetrix 500K and Illumina 300K chipsets to detect as-
sociation (Pe’er et al. 2006). Since then, the Illumina 550K
chipsethasbecomeavailable.Amorerecentreport(Zaitlen
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et al. 2007) proposed a new method for multimarker anal-
ysis called WHAP and provided software to implement it
on the Affymetrix 500K and Illumina 550K chipsets. It
reported that, with a sample size of 2000, a disease preva-
lence of 0.01 and a relative risk of 1.5, the power of single
SNP analysis to detect association at p < 0.01 with these
chipsets was 0.92 and 0.98 respectively and the power using
the WHAP method was 0.96 and 0.99. A second recent
report (Magi et al. 2007) compared the extent to which
the four chipsets are able to tag other SNPs in different
ethnic groups by measuring the percentage of SNPs cov-
ered with r2 > 0.8 and by measuring the mean r2 be-
tween each SNP and its best tagging SNP. It was found
that in a European population the Illumina 550K set pro-
vided 86% coverage, followed by the Illumina 300K (76%),
Affymetrix 500K (64%) and ﬁnally Affymetrix 100K
(32%).
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Because microsatellites have a larger number of alleles
than SNPs one might expect from a theoretical point of
view that they could be more powerful to detect associa-
tion (Sham et al. 2000). Against this, their higher mutation
rate might make LD decay more swiftly. Nevertheless, it
has been shown that LD can be detectable between mi-
crosatellites over long distances (Sherrington et al. 1991),
implying that LD with a pathogenic variant might also be
detectable in association studies of disease. Hence it is dif-
ﬁcult to judge a priori the relative beneﬁts of each type of
marker. One would also want to consider issues such as the
cost, speed and convenience of genotyping, factors which
constantly change as new technology develops. If it were
to be shown that one or other type of marker were bet-
ter able to detect association then this in itself would act
as a spur to further technological reﬁnements. Although
the current fashion seems to be to move towards SNPs in
order to carry out systematic testing for association over
a region and indeed over the whole genome, it might be
that microsatellites could be useful in this role. The relative
usefulness of SNPs and microsatellites has not previously
been systematically studied.
Rather than reporting the proportion of polymorphisms
tagged, the present study uses simulation methods to pro-
vide a real world assessment of the relative power of
the Affymetrix 500K, Illumina 300K and Illumina 550K
chipsets to detect an associated disease locus. Separately,
it measures the extent of LD between microsatellites and
nearby SNPs with a view to assessing the ability of mi-
crosatellites to detect association.
Methods
We havepreviouslydescribedinmoredetailthegeneralapproach
of using simulations to assess the power of SNPs to detect asso-
ciation (North et al. 2006). In essence, the method consists of
using real SNP genotypes from the HapMap project (HapMap
Consortium 2003) to produce simulated data for a case-control
study based on observed SNP allele frequencies and LD relation-
ships.ThescenarioenvisagedisthatoneSNPaffectssusceptibility
to disease but has not been genotyped. Available to the investi-
gator are the phase-unknown genotypes of nearby markers and
the aim is to detect association with the disease phenotype in the
context of a case-control association study.
Original SNP Genotypes
SNPs covering regions extending from 5 cM to 10 cM of
chromosomes 1 to 5 were downloaded from the HapMap site
(www.HapMap.org).Genotypesweretakenfor60unrelatedsub-
jects, who are parents in the 30 trios comprising the CEPH
dataset. 1000 consecutive SNPs having minor allele frequency
(MAF) of at least 0.05 were selected from the midst of each of
these 5 regions. The cut-off of using MAF ≥ 0.05 was designed
to exclude HapMap SNPs which were monomorphic or nearly
monomorphic in this population. These 1000 SNPs were used as
simulated disease loci and were studied along with the surround-
ing SNPs.
TheHapMapSNPsweredownloadedfromtheHapMapweb-
site (www.HapMap.org).
Estimation of Disease-Marker Haplotypes
For the 5000 SNPs to be studied we selected each SNP in turn to
be treated as if it were a disease susceptibility locus. We wished to
investigate the ability of other SNPs nearby to detect association
with the disease phenotype. In order to gain an idea of the prob-
ability for at least one marker or group of markers to be able to
detect the effect of the disease locus we carried out analyses with
several neighbouring markers. For each selected disease locus we
usedneighbouringSNPstoactasmarkersandusedmarkersetsof
different sizes ranging from 1 to 4 contiguous markers to form a
sliding window, while skipping the disease locus itself. We chose
6 sets of each size, 3 on either side of the disease locus, with the
ﬁrst marker shifting by one position each time. Thus, for single
marker analyses we used 1 of 3 single markers on either side of
the disease locus whereas for the 4-marker analyses we used 6
overlapping windows of 4 markers at a time. For each combina-
tion of disease and marker loci we obtained estimated haplotype
frequencies in the downloaded genotypes using the SNPHAP
program (www.gene.cimr.cam.ac.uk/clayton/software/). These
haplotype frequencies estimated from real data were then used to
generatesimulatedsetsofmarkergenotypes,suchasmightbeob-
served in case-control studies were the marker(s) to be typed in a
sampleinwhichthedisease locusexertedaneffectonsusceptibil-
ity. No minimum frequency was set for these haplotypes, though
obviously haplotypes with very low frequency would only rarely
be sampled in the simulations.
Simulation of Genotypes
For each disease locus a penetrance of 0.01 was used for subjects
having no copies of the disease allele, while for subjects having
one or two copies of the disease allele the penetrance was set to
0.02. The allele frequencies of the disease locus were taken to be
the observed frequencies of the SNP under consideration. As de-
scribed previously (North et al. 2006), the expected proportions
of cases and controls having 0, 1 or 2 copies of the disease allele
were calculated using this transmission model under the assump-
tion of Hardy-Weinberg equilbrium within the population. A
simulated sample of 400 cases and 400 controls was then gener-
ated. Each case or control was ﬁrst randomly allocated a number
of disease alleles according to the probabilities equal to the ex-
pected proportions. Then two haplotypes bearing this number of
disease alleles were sampled at random according to the estimated
haplotype frequencies obtained from the SNPHAP program.
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Use of Different Marker Sets
The procedure described was carried out assuming that 4 differ-
ent samples of SNPs were available to use as markers. Firstly, we
utilised all available HapMap SNPs. Alternatively, we restricted
our use of markers to those included in different chipsets. The list
of SNPs for the Affymetrix 500K array chipset was downloaded
from the Affymetrix website (www.affymetrix.com) and the lists
of the Illumina 300K and 550K chipsets were downloaded from
the Illumina website (www.illumina.com). For each disease lo-
cus we obtained simulated marker genotypes using one of these
four marker samples, i.e. all HapMap markers, Affymetrix 500K,
Illumina 300K or Illumina 550K. For all four marker samples
we used ﬂanking SNPs as markers but did not include the actual
disease locus genotypes in the data available to be analysed.
Analysis of Simulated Genotypes
The genotypes obtained from the above procedure were anal-
ysed using two methods: a test for heterogeneity of haplotype
frequencies using RUNGC and logistic regression. For hetero-
geneity testing the GENECOUNTING program and RUNGC
support program were used (Zhao et al. 2002; Curtis et al. 2006).
The GENECOUNTING program estimates maximum likeli-
hood haplotype frequencies from unphased multilocus geno-
types, which may include multiallele genotypes and missing
data. It also outputs a log likelihood for the dataset assuming
these frequencies. The RUNGC program constructs a test for
heterogeneity of haplotype frequencies by obtaining these max-
imisedloglikelihoodsforthecontrols,thecasesandthecombined
dataset. A likelihood ratio statistic (LRS) is derived as 2(LCASE +
LCONTROL − LCOMBINED)andthisistakenasachi-squaredstatis-
tic with degrees of freedom equal to the difference in the number
of haplotypes estimated to have non-zero frequency in the cases
plus the controls compared to the combined dataset.
In addition to heterogeneity testing, logistic regression anal-
ysis was used to test for the main effects of each marker locus.
The A allele at each marker SNP was arbitrarily chosen as a risk
factor which might inﬂuence risk so that genotypes AA, AB and
BB would correspond to exposure of 2, 1 or 0. No interaction
terms of independent variables were included in this analysis.
This method had been implemented within the simulation pro-
gram and logistic regression was carried out to estimate the log
likelihoods for the dataset assuming no genetic effect on risk or
assuming that the risk allele at each marker locus exerted an in-
dependent effect, producing a LRS having degrees of freedom
equal to the number of marker SNPs included in the analysis.
For single markers, this method is asymptotically equivalent to
the Armitage test for trend.
For each disease locus we analysed the 6 simulated sets of
marker genotypes using both heterogeneity testing and logistic
regression and then we noted whether any of the sets produced
evidence for association at p < 0.001. This level of signiﬁcance
waschosenarbitrarilyasbeingonewhichsomeresearcherswould
regard as being of interest in terms of possibly indicating associ-
ation for a plausible candidate gene and as being achievable in a
reasonable proportion of trials with the chosen sample size and
genetic model. We carried out this process for sets of 1, 2, 3 and
4 markers.
Obtaining Microsatellite Genotypes
The microsatellite genotypes were obtained from the CEPH
genotype database (ftp://ftp.cephb.fr/ceph genotype db/ceph
db/Ver 10/) through a process which proved surprisingly
complex. The mkr directory contains ﬁles providing information
on all of the 32356 available markers. Markers whose names
were D numbers were selected from the mkr ﬁles and those with
more than two alleles and heterozygosity rate greater than 0.5
were selected as possibly being microsatellites. The positions of
thesemicrosatelliteswerethenobtainedfromtheUCSCGenome
Bioinformatics table browser (http://genome.ucsc.edu/cgi-
bin/hgTables), which provides an alias ﬁle and a map ﬁle. For a
given region, the alias ﬁle gives aliases for the D numbers, which
can then be found in the map ﬁle, which gives the microsatellite
positions. The asc directory contains ﬁles which give genotypes
for the subjects in the CEPH families. Individuals are identiﬁed
by their family ID and their within-family ID, which differ
from the ID used by HapMap. Pedigree information on the
30 CEPH trios included in the HapMap project is available
at http://www.HapMap.org/downloads/samples individuals/.
This enables an individual with a HapMap subject id to be
located within the CEPH genotype (asc) ﬁles and enabled us
to obtain genotypes for putative microsatellites matched to the
HapMap subjects for which we already had SNP data.
Assessing Ability of Microsatellites to Detect
Association with Nearby SNPs
Our original intention had been to treat the microsatellites in
the same way as we had treated marker SNPs and to produce
simulated microsatellite genotypes based on a simulated disease
locus effect of a test SNP and estimated LD relationships be-
tween that SNP and microsatellites nearby. However we were
unable to proceed with this for two reasons. Firstly, it emerged
that of the microsatellites typed in CEPH pedigrees very few
had genotypes available for the parents whose SNP genotypes
were available from HapMap. Other members of the pedigrees
tended to be genotyped instead. This meant that there were not
microsatellite genotypes available in the regions which we had
studied for the SNP simulations. Secondly, we realised that with
the relatively small number of subjects we had available estimates
of SNP-microsatellite haplotypes might not be sufﬁciently accu-
rate to produce meaningful simulations. If a microsatellite had a
large number of alleles then the maximum likelihood estimate
for the haplotype frequencies might be critically dependent on
observationsinjustoneortwoindividuals.Ifestimatedhaplotype
frequencies are taken to represent the true population frequencies
and are then used in a simulation procedure such as that imple-
mented above then when a large sample is generated there is a
risk of strongly exaggerating the extent of LD between the test
SNP and marker microsatellites. This process can lead to the pro-
duction of very unrealistic simulation results. Reports elsewhere
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Table 1 D-numbers, start positions, marker type and heterozygosity
rate are shown for the ten chromosome 1 microsatellites used for tests
for LD with nearby SNPs.
Start Enzyme/ Heterozygosity
D-number position Marker type rate
D1S1597 13656694 (GATA)n 0.78
D1S164 33652218 (AC)n 0.78
D1S168 39762119 (AC)n 0.55
D1S162 50669089 (AC)n 0.84
D1S159 69991533 (AC)n 0.63
D1S1679 160628387 GGAA5F09/pcr 0.83
D1S1677 161826323 GGAA22G10/pcr 0.74
D1S178 230426715 (AC)n 0.64
D1S163 232925994 (AC)n 0.73
D1S180 239431757 (AC)n 0.88
highlight similar dangers when estimated haplotype frequencies
are treated as if they accurately represented population frequen-
cies (Curtis & Sham 2006; Curtis & Xu 2007).
Instead we adopted a different approach. Firstly, we identiﬁed
all microsatellites on chromosome 1 which had been genotyped
in at least 40 of the CEPH parents. Out of a total of 5,000 on
chromosome 1 there were 10 which met this criterion and they
are listed in Table 1. Next, we downloaded from HapMap all
SNPs within 2 Mb of each microsatellite.
InordertomeasuretheextentofLDbetweeneachmicrosatel-
lite and a nearby SNP we calculated the signiﬁcance of a likeli-
hood ratio test for LD as implemented in the LDPAIRS program
(Curtis et al. 2006). This calculates the log likelihood for geno-
types at two loci assuming that there is no LD between them
and then calculates the log likelihood assuming maximum like-
lihood estimates for the haplotype frequencies allowing for LD.
Twice the difference between the log likelihoods is taken to be
distributed as chi-squared with degrees of freedom equal to NM-
N-M+1, where N and M are the numbers of alleles at each lo-
cus. We took −log(p) as providing some kind of indication as to
whether or not there was evidence for some level of detectable
LD between the microsatellite and the SNP and for each SNP
we graphed this against the distance away from the microsatel-
lite. Using this approach, a relatively small sample is not expected
to produce artefactual evidence of LD as it would if simulation
procedures were applied. The LDPAIRS program also outputs
two measures of LD, Cramer’s V and D’ between the common-
est alleles at the two loci. However for the present application we
thought that the signiﬁcance of the test for LD would provide
a better guide to the likely ability of a microsatellite to demon-
strate signiﬁcant evidence for association in a case-control study
in which the SNP exerted an effect on risk.
Results
Power of SNPs to Detect Association
Resultsfromheterogeneitytestingofhaplotypefrequencies
and of logistic regression analysis were similar but the lat-
Table 2 The proportions of 5000 simulated disease loci for which
at least one of the six sliding window logistic regression analyses gave
a p value of less than 0.001.
Number of markers in sliding window
S N P s e t 1234
All HapMap 0.44 0.47 0.47 0.46
Affymetrix 500K 0.36 0.40 0.41 0.41
Illumina 300k 0.37 0.43 0.44 0.44
Illumina 550k 0.39 0.45 0.45 0.46
ter method was slightly more powerful. Hence only results
from logistic regression analysis will be considered further.
Likewise, results for the ﬁve different chromosomal regions
studied were similar to each other and hence were pooled.
Table2showstheproportionofthe5,000simulateddisease
loci for which at least one of the six ﬂanking marker sets
tested was signiﬁcant at p < 0.001. The following points
can be made. Firstly, the overall power to detect association
bythiscriterionisintheregionof0.4.Ofcourse,thisﬁgure
would be critically dependent on disease model and sam-
ple size and is not the main emphasis of this investigation.
Secondly, we note that the power increases somewhat (by
around 0.05) when we move from single marker analysis
to two marker analysis. However using three or four mark-
ers does not produce any further notable increase in power
to detect association. Finally, we note that the Affymetrix
500K chipset is somewhat less powerful (by around 0.07)
than using all HapMap markers, that the Illumina 300K
chipset loses a little less power (around 0.05) and that when
using two marker analysis the Illumina 550K chipset loses
minimal power (around 0.02).
Extent of LD Between Microsatellites
and Nearby SNPs
Figure 1 shows the extent of LD between the ten mi-
crosatellites investigated and the SNPs surrounding them,
measured as −log(p). Even though only ten have been
studied, it is clear that the patterns of LD vary widely be-
tween the microsatellites. For D1S159 and D1S1679 the
pattern is perhaps close to what might be expected. There
are a few SNPs which are very close (within a few kb)
which show very strong evidence for LD whereas SNPs
further away conform to chance expectation. By contrast,
D1S162 appears to show evidence for LD with markers
ranging up to 1.3 Mb away on one side but not with any
markers on the other side of it. Other microsatellites, such
as D1S1597, D1S164 and D1S168 show more moderate
evidence for LD with nearby markers which arguably falls
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Figure 1 Values for −log(p) for the test for LD between microsatellites and SNPs lying
within 2 Mb.
off more gradually with markers which are further away.
Overall, we would argue that these results demonstrate two
features. Firstly, only a small proportion of SNPs demon-
strate LD with microsatellites even within a distance as
small as 100 kb. Secondly, the pattern of LD relationships
between microsatellites and SNPs is very inconsistent and
in particular some microsatellites show quite strong evi-
dence for LD with SNPs which are quite distant while
others do not.
Discussion
The emphasis of this investigation is to assess the relative
ratherthanabsolutepowerofdifferentmarkersetstodetect
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Figure 1 Continued
association of a marker with a disease phenotype. Never-
theless perhaps it is worth commenting that with the dis-
ease model and sample size used less than half of simulated
loci produce evidence of association at the level of p <
0.001 with any nearby marker SNP. Where there is some
degree of LD between the disease locus and marker one
would expect the evidence for association to increase with
increasedsamplesizeand/orincreasedgeneticeffect.How-
ever if there are susceptibility polymorphisms which have
no or very weak LD with neighbouring polymorphisms
then they will not be detected by association studies unless
they themselves are genotyped.
Because we were interested in the relative power of the
different marker chipsets, we have not investigated using
other disease models or other methods of analysis. We
might expect that while a different disease model could
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have a profound effect on the absolute power to detect as-
sociation the relative power might not be greatly affected.
Of course, we cannot be sure that there would not be
circumstances in which some disease models might be rel-
atively better suited to different marker chipsets and if this
question were regarded as being of crucial importance then
further studies could be performed. We note that the hap-
lotype analysis using the asymptotic chi-squared distribu-
tion was less powerful than logistic regression analysis. It
is to be expected that if no lower limit is set to estimated
haplotype frequencies, as in the present case, then there
may be an increased probability of both Type 1 and Type 2
errors when the asymptotic distribution is used and it has
been reported elsewhere (Curtis, 2007) that the power of
C   2008 The Authors
Journal compilation C   2008 University College London
Annals of Human Genetics (2008) 72,547–556 553D. Curtis et al.
Figure 1 Continued
haplotype analysis is improved when permutation testing is
used instead. We have not investigated the ability of newer
multimarker methods to detect association (Minichiello &
Durbin, 2006; Curtis, 2007; Zaitlen et al. 2007). These
methods have yet to be taken up widely. Once again, it
is not impossible that different marker chipsets could be
better suited to different methods and if this were thought
to be the case then further investigations could be carried
out.
In terms of relative power, we conclude that all three
of the chipsets studied have fairly good power relative to
typing all available HapMap markers. In particular, the Il-
lumina 550K chipset loses only minimal power, especially
if two marker rather than single marker analysis is used. As
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chipsets are introduced which include even more markers
it may be useful to investigate how much additional power,
if any, they yield.
The Illumina 550K markers have been specially selected
to tag other SNPs which can be predicted from haplotypes
of pairs of the Illumina markers. We deliberately chose
to use an information-free method for combining infor-
mation from multiple markers. Our reasoning was that,
although the tagging method might allow the detection
of association with known polymorphisms, we were inter-
ested in the ability of the markers to detect association with
polymorphisms which might as yet be unknown. Even
without introducing prior information about known LD
relationships between pairs of Illumina markers and other
HapMap SNPs we found that standard two locus logistic
regression analysis using the Illumina 550K chipset yielded
very good power.
With regard to the microsatellites, our conclusion is that
they are not suitable for systematic tests for association.
Each microsatellite demonstrates LD with only a small
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proportion of SNPs lying within 100 kb. Thus if one of
these SNPs had an effect on risk of affection there would
only be a small probability that the microsatellite would
demonstrate association in a case-control study. Since mi-
crosatellites on the CEPH database are spaced at an average
ofaround500kbitseemsthatevenifallknownmicrosatel-
litesweregenotypedtheywouldstillbeunabletodetectas-
sociation with the vast majority of known polymorphisms.
An additional, more minor, problem is that they appear
to demonstrate quite variable patterns of LD and would
sometimes detect association with markers which were a
largedistance(>1 Mb) away. Thiswouldmakeitmoredif-
ﬁcult to incorporate results from microsatellite genotyping
into ﬁne-mapping investigations. Although SNPs may also
demonstrate variable patterns of LD and may sometimes
demonstrate LD over long distances, we would argue that
the fact that SNPs are far more numerous than microsatel-
lites makes the utilisation of SNPs in association studies
relatively less difﬁcult. Where one is interested in a par-
ticular candidate gene or region it may be worth typing
microsatellites nearby in case they happen to enhance evi-
denceforassociation.Howeveringeneralweconcludethat
the use of microsatellites for systematic association studies
is problematic.
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